CD8A and neoplasm: The ability of CD8 positive cytotoxic T lymphocytes to infiltrate the tumor microenvironment determines the sensitivity of NSCLC to immunotherapy, which likewise induces an increase in PD-L1 expression and γ Interferon production (42).